{"DataElement":{"publicId":"3269803","version":"1","preferredName":"Biomarker Peroxisome Proliferative Activated Receptor Gamma Testing Outcome Staining Intensity Number Score","preferredDefinition":"Numeric score to represent the staining strength or intensity of peroxisome proliferative activated receptor gamma (PPARy) testing.","longName":"PPARY_STN_INTY_SC","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2969419","version":"1","preferredName":"Biomarker Peroxisome Proliferative Activated Receptor Gamma Testing Outcome","preferredDefinition":"Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc_A procedure for critical evaluation; a means of determining the presence, quality, or truth of something._Expressed as multiple variants in adipose tissue (highest), skeletal muscle, spleen, heart, liver placenta, lung, and ovary by human PPARG Gene (NR1/PPAR Family), nuclear Peroxisome Proliferative Activated Receptor Gamma heterodimerizes with RXRs and NCOA6 coactivator to regulate target gene transcription. A receptor that binds peroxisome proliferators, such as hypolipidemic drugs and fatty acids, PPARG is a key regulator of adipocyte differentiation and glucose homeostasis. Once activated by ligand, PPARG binds to an acyl-CoA oxidase gene promoter element, activates transcription, and controls the peroxisomal fatty acid beta-oxidation pathway. Defects in PPARG can lead to type 2 insulin-resistant diabetes and hypertension. (NCI)_Outcome; a phenomenon that follows and is caused by some previous phenomenon_","longName":"BIOMK_PPARG_TST_RSL","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2969417","version":"1","preferredName":"Biomarker Peroxisome Proliferative Activated Receptor Gamma","preferredDefinition":"Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc:Expressed as multiple variants in adipose tissue (highest), skeletal muscle, spleen, heart, liver placenta, lung, and ovary by human PPARG Gene (NR1/PPAR Family), nuclear Peroxisome Proliferative Activated Receptor Gamma heterodimerizes with RXRs and NCOA6 coactivator to regulate target gene transcription. A receptor that binds peroxisome proliferators, such as hypolipidemic drugs and fatty acids, PPARG is a key regulator of adipocyte differentiation and glucose homeostasis. Once activated by ligand, PPARG binds to an acyl-CoA oxidase gene promoter element, activates transcription, and controls the peroxisomal fatty acid beta-oxidation pathway. Defects in PPARG can lead to type 2 insulin-resistant diabetes and hypertension. (NCI)","longName":"C16342:C34077","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biomarker","conceptCode":"C16342","definition":"A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Peroxisome Proliferator-Activated Receptor Gamma","conceptCode":"C34077","definition":"Peroxisome proliferator-activated receptor gamma (505 aa, ~58 kDa) is encoded by the human PPARG gene. This protein plays a role in transcriptional regulation, lipid metabolism, cell differentiation, glucose homeostasis and apoptosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7AC109C2-2FE5-5C6A-E040-BB89AD4314B5","latestVersionIndicator":"Yes","beginDate":"2009-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-15","modifiedBy":"ONEDATA","dateModified":"2009-12-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2527278","version":"1","preferredName":"Testing Result","preferredDefinition":"A procedure for critical evaluation.:Outcome; a phenomenon that follows and is caused by some previous phenomenon.","longName":"C15336:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Testing","conceptCode":"C15336","definition":"A procedure for critical evaluation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1F9F4B5C-5E58-18D6-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-10-12","modifiedBy":"ONEDATA","dateModified":"2006-10-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7AC109C2-2FF3-5C6A-E040-BB89AD4314B5","latestVersionIndicator":"Yes","beginDate":"2009-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-15","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2231047","version":"1","preferredName":"Immunohistochemistry Staining Intensity Number Score","preferredDefinition":"Numeric score to represent the strength of an immunohistochemistry (IHC) analysis result.","longName":"IHC_STAIN_INTS_SC","context":"SPOREs","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"8","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"0","valueDescription":"No Staining","ValueMeaning":{"publicId":"2575450","version":"1","preferredName":"No Staining","longName":"2575450","preferredDefinition":"No Staining","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F3C7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-29","modifiedBy":"REEVESD","dateModified":"2005-06-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FA77AA60-E2B3-02A3-E034-0003BA3F9857","beginDate":"2005-06-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-29","modifiedBy":"REEVESD","dateModified":"2005-06-29","deletedIndicator":"No"},{"value":"1","valueDescription":"Weak","ValueMeaning":{"publicId":"2574560","version":"1","preferredName":"Weak","longName":"2574560","preferredDefinition":"Having strength, power, or intensity less than average or expected.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Weak","conceptCode":"C62224","definition":"Having strength, power, or intensity less than average or expected.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F04D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-04-21","modifiedBy":"CURTIST","dateModified":"2006-11-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F7C5E8C3-16CF-19DD-E034-0003BA3F9857","beginDate":"2005-05-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-25","modifiedBy":"REEVESD","dateModified":"2005-05-25","deletedIndicator":"No"},{"value":"2","valueDescription":"Moderate","ValueMeaning":{"publicId":"2563415","version":"1","preferredName":"Moderate","longName":"2563415v1.00","preferredDefinition":"The quality of being within reasonable or average limits; not excessive or extreme.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Moderate","conceptCode":"C61376","definition":"The quality of being within reasonable or average limits; not excessive or extreme.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C4C4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"MMADDINENI","dateModified":"2023-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F7C5E8C3-16D0-19DD-E034-0003BA3F9857","beginDate":"2005-05-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-25","modifiedBy":"SBREXT","dateModified":"2007-06-22","deletedIndicator":"No"},{"value":"3","valueDescription":"Strong","ValueMeaning":{"publicId":"2573780","version":"1","preferredName":"Strong","longName":"2573780","preferredDefinition":"Strong","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-ED41-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-24","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-03-24","modifiedBy":"MAESKEB","dateModified":"2005-03-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F7C5E8C3-16D1-19DD-E034-0003BA3F9857","beginDate":"2005-05-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-25","modifiedBy":"REEVESD","dateModified":"2005-05-25","deletedIndicator":"No"},{"value":"4","valueDescription":"Very strong","ValueMeaning":{"publicId":"3008632","version":"1","preferredName":"Very strong","longName":"3008632","preferredDefinition":"Very strong","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F33B84A-60AF-BF55-E040-BB89AD437CF7","latestVersionIndicator":"Yes","beginDate":"2010-02-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7F33B84A-60C8-BF55-E040-BB89AD437CF7","beginDate":"2010-02-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-09","modifiedBy":"ONEDATA","dateModified":"2010-02-09","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2208143","version":"1","preferredName":"Number Score","preferredDefinition":"Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification.:A number or range of numeric values measuring performance, function, quality, or ability.","longName":"C25337:C25338","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Number","conceptCode":"C25337","definition":"A numeral or string of numerals expressing value, quantity, or identification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3F53-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F7C5E8C3-16B9-19DD-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-25","modifiedBy":"REEVESD","dateModified":"2010-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2812571","version":"1","longName":"Lombardi Cancer Center","context":"NCIP"},{"publicId":"2812605","version":"1","longName":"Lombardi New CDEs","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Staining Intensity (choose on","type":"Preferred Question Text","description":"Staining Intensity (choose one from 0, 1, 2, 3, 4)+","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"AC46B303-415C-EC24-E040-BB89AD431A2A","latestVersionIndicator":"Yes","beginDate":"2011-09-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-09-06","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeDescription":"Curated to support Lombardi Cancer Center clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}